Under construction – not a live service
Sign in
Taking people in PortugalNo phase

Tests a Mediterranean-style diet with fermented foods in rheumatoid arthritis

Tests a Mediterranean-style diet with fermented foods in adults with rheumatoid arthritis.

Plain-language title generated from the registry record
Registry title: The Triad of Nutrition, Intestinal Microbiota and Rheumatoid Arthritis (TASTY)

Key facts

Where
Lisbon, PortugalSee the 2 sites

Where in Portugal

  • Faculdade Medicina de LisboaLisbon, PortugalTaking people
  • Unidade Local de Saúde de Santa MariaLisbon, PortugalTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa
Trial code
NCT06758817
Record updated
6 January 2025
Original description
The main goal of this trial is to investigate whether a dietary intervention based on a typical Mediterranean Diet enriched with fermented foods (MedDiet+) can impact gut microbiota and RA-related outcomes.Read full original descriptionShow less

The Triad of Nutrition, Intestinal Microbiota and Rheumatoid Arthritis (TASTY)

The main goal of this trial is to investigate whether a dietary intervention based on a typical Mediterranean Diet enriched with fermented foods (MedDiet+) can impact gut microbiota and RA-related outcomes.

Inclusion: RA patients (ACR/EULAR2010 criteria); Age >18-years; Disease duration >1-year; Active disease (DAS28 > 2.6units); On stable medication for 12 weeks; Low/medium MedDiet adherence (PREDIMED<10); Willing to comply with study protocol.

Exclusion: Antibiotic therapy 4-weeks prior to baseline; Inflammatory or irritable bowel disease; Celiac disease; Diabetes; Other immune-mediated inflammatory diseases besides RA; Cancer diagnosed in the last five years; Health conditions which may difficult participation (cognitive impairment/psychiatric disease); Prednisolone dose ≥ 7.5 mg/day; Persistent use of NSAID's; Chronic diarrhea; Major organ dysfunction; Pregnant or lactating individuals.

ClinicalTrials.gov NCT06758817